Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose–response meta-analysis.

Purpose: Aspirin has been suggested to reduce the risk of cancer. However, previous studies have been inconsistent regarding the relationship between aspirin use and the risk of occurrence of hepatocellular carcinoma (HCC). The purpose of this study was to assess the effect of aspirin on clinical ou...

Full description

Bibliographic Details

Published in:	European Journal of Clinical Pharmacology Vol. 79; no. 1; pp. 39 - 62
Main Authors:	Ma, Shaodi, Qu, Guangbo, Sun, Chenyu, Liu, Haixia, Jiang, Yuemeng, Li, Ning, Wu, Birong, Gao, Juan, Feng, Linya, Xie, Peng, Xia, Weihang, Kim, Na Hyun, Lowe, Scott, Bentley, Rachel, Zhu, Yike, Zhou, Qin, Sun, Yehuan
Format:	meta analysis research systematic review tables/charts Journal Article
Published:	Springer Nature Jan2023
Online Access:	View this record in EBSCOhost